Skyrizi 00074-8350

Generic: Risankizumab-Rzaa

Product NDC

00074-8350

Manufacturer: Abbvie Inc.
Dosage Form: Injection
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: September 3, 2025
Listing Expires: December 31, 2027
Application: BLA761105

Need to source Skyrizi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Risankizumab	180 mg/1.2mL

Drug Class

Interleukin-23 Antagonist [EPC]Interleukin-23 Antagonist [EPC]Interleukin-23 Antagonists [MoA]

Packaging Options(1)

00074-8350-01

2 SYRINGE in 1 CARTON (0074-8350-01) / 1.2 mL in 1 SYRINGE

View →